Ameriprise
SBBP

Ameriprise’s Strongbridge Biopharma plc. SBBP Stock Holding History

Ameriprise’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-26,179
Closed -$72K – 4012
2021
Q1 		$72K Sell
26,179
-66,225
-72% -$200K ﹤0.01% 3791
2020
Q4 		$225K Sell
92,404
-22,404
-20% -$54K ﹤0.01% 3597
2020
Q3 		$241K Buy
114,808
+44,655
+64% +$151K ﹤0.01% 3486
2020
Q2 		$266K Buy
70,153
+8,341
+13% +$25K ﹤0.01% 3402
2020
Q1 		$117K Buy
61,812
+31,102
+101% +$80.8K ﹤0.01% 3522
2019
Q4 		$64K Buy
+30,710
New +$58.9K ﹤0.01% 3660

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Ameriprise's SBBP Position: Q2 2021 in Review

Ameriprise sold out of Strongbridge Biopharma plc. (SBBP) in Q2 2021, closing a stake of 26,179 shares — an estimated $72K sold.

Ameriprise first reported a position in SBBP in Q4 2019 and held it in 6 quarters. The position peaked at $266K in Q2 2020. 59 funds tracked by Wall St. Rank hold SBBP as of Q2 2021.

  • Ameriprise reported no remaining Strongbridge Biopharma plc. position as of Q2 2021 after selling out during the quarter.
  • Ameriprise sold 26,179 Strongbridge Biopharma plc. shares in Q2 2021, an estimated $72K.
  • Ameriprise first reported a position in Strongbridge Biopharma plc. in Q4 2019 and held it in 6 quarters.
  • Ameriprise's Strongbridge Biopharma plc. position peaked at $266K in Q2 2020.
  • 59 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q2 2021.

Based on Ameriprise's 13F filing for Q2 2021, filed 16 Aug 2021.